Todd F. Baumgartner, M.D., MPH

Todd F. Baumgartner, M.D., MPH has extensive work experience in the pharmaceutical industry. Todd F. is currently serving as the Senior Vice President for Global Regulatory Affairs, Pharmacovigilance, and Biometrics at Ovid Therapeutics since September 2020. Prior to that, they held the position of Senior Vice President for Regulatory Affairs and Clinical Operations at Acorda Therapeutics, Inc. from January 2015 to September 2020.

Before Acorda Therapeutics, Inc., Dr. Baumgartner worked at Purdue Pharma L.P. as the Chief Medical Officer - Vice President of Research and Development from April 2014 to January 2015. Additionally, they served as the Vice President of Regulatory Affairs at Purdue Pharma L.P. from November 2009 to July 2014.

Earlier in their career, Dr. Baumgartner held various positions at AstraZeneca and Bristol-Myers Squibb. At AstraZeneca, they were the Vice President for Global Regulatory Policy, Intelligence, and Labeling from July 2008 to October 2009. During their time at Bristol-Myers Squibb, they served as the Vice President for Global Regulatory Sciences - Intercontinental from August 2004 to March 2008. Prior to that, they held the roles of Vice President for Global Regulatory Strategy and Executive Director for Medical and Scientific Affairs in Australia and New Zealand at Bristol-Myers Squibb.

Dr. Baumgartner began their career as the Director of Infectious Diseases Clinical Research at Bristol-Myers Squibb in June 1992. Todd F. held this position until December 1998, during which they transitioned to the role of Executive Director for Medical and Scientific Affairs in Australia and New Zealand. Todd F. later became the Vice President for Global Regulatory Strategy at Bristol-Myers Squibb from October 2000 to April 2004.

Overall, Dr. Todd F. Baumgartner has demonstrated expertise in regulatory affairs, clinical operations, and research and development throughout their career in the pharmaceutical industry.

Todd F. Baumgartner, M.D., MPH pursued their education in a chronological manner. First, they attended St. Louis Country Day School, where the specific years and any degrees or fields of study remain unknown. Subsequently, they enrolled at Duke University from 1978 to 1981 and completed a Bachelor of Arts (B.A.) degree in History and English. Continuing their academic journey, they attended the University of Missouri-Columbia, School of Medicine, from 1982 to 1986 and obtained a Medical Doctor (M.D.) degree with a field of study in Medicine. Lastly, in 1987-1988, they attended the University of California, Berkeley, where they completed a Master's in Public Health (M.P.H.) degree with a focus on Epidemiology within the field of Public Health.